These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 35710995)

  • 1. Genome-wide polygenic score to predict chronic kidney disease across ancestries.
    Khan A; Turchin MC; Patki A; Srinivasasainagendra V; Shang N; Nadukuru R; Jones AC; Malolepsza E; Dikilitas O; Kullo IJ; Schaid DJ; Karlson E; Ge T; Meigs JB; Smoller JW; Lange C; Crosslin DR; Jarvik GP; Bhatraju PK; Hellwege JN; Chandler P; Torvik LR; Fedotov A; Liu C; Kachulis C; Lennon N; Abul-Husn NS; Cho JH; Ionita-Laza I; Gharavi AG; Chung WK; Hripcsak G; Weng C; Nadkarni G; Irvin MR; Tiwari HK; Kenny EE; Limdi NA; Kiryluk K
    Nat Med; 2022 Jul; 28(7):1412-1420. PubMed ID: 35710995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Including APOL1 alleles and ancestry adjustments improve a genome-wide polygenic CKD score.
    Yu Z; Wuttke M
    Kidney Int; 2022 Nov; 102(5):954-955. PubMed ID: 35985372
    [No Abstract]   [Full Text] [Related]  

  • 3. Genome-Wide Polygenic Risk Score for CKD in Individuals with APOL1 High-Risk Genotypes.
    Vy HMT; Coca SG; Sawant A; Sakhuja A; Gutierrez OM; Cooper R; Loos RJF; Horowitz CR; Do R; Nadkarni GN
    Clin J Am Soc Nephrol; 2024 Mar; 19(3):374-376. PubMed ID: 37962879
    [No Abstract]   [Full Text] [Related]  

  • 4. Cross-ancestry genome-wide polygenic score predicts chronic kidney disease.
    Nat Med; 2022 Jul; 28(7):1355-1356. PubMed ID: 35739270
    [No Abstract]   [Full Text] [Related]  

  • 5. APOL1 Nephropathy Risk Alleles and Mortality in African American Adults: A Cohort Study.
    Gutiérrez OM; Irvin MR; Zakai NA; Naik RP; Chaudhary NS; Estrella MM; Limou S; Judd SE; Cushman M; Kopp JB; Winkler CA
    Am J Kidney Dis; 2020 Jan; 75(1):54-60. PubMed ID: 31563468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An investigation of APOL1 risk genotypes and preterm birth in African American population cohorts.
    Robertson CC; Gillies CE; Putler RKB; Ng D; Reidy KJ; Crawford B; Sampson MG
    Nephrol Dial Transplant; 2017 Dec; 32(12):2051-2058. PubMed ID: 27638911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Genetic African Ancestry on eGFR and Kidney Disease.
    Udler MS; Nadkarni GN; Belbin G; Lotay V; Wyatt C; Gottesman O; Bottinger EP; Kenny EE; Peter I
    J Am Soc Nephrol; 2015 Jul; 26(7):1682-92. PubMed ID: 25349204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A polygenic score predicts CKD across ancestries.
    Steinbrenner I; Köttgen A
    Nat Rev Nephrol; 2022 Nov; 18(11):681-682. PubMed ID: 35953653
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic Inhibition of APOL1 Pore-Forming Function Prevents APOL1-Mediated Kidney Disease.
    Hung AM; Assimon VA; Chen HC; Yu Z; Vlasschaert C; Triozzi JL; Chan H; Wheless L; Wilson O; Shah SC; Mack T; Thompson T; Matheny ME; Chandrasekar S; Mozaffari SV; Chung CP; Tsao P; Susztak K; Siew ED; Estrada K; Gaziano JM; Graham RR; Tao R; Hoek M; Robinson-Cohen C; Green EM; Bick AG;
    J Am Soc Nephrol; 2023 Nov; 34(11):1889-1899. PubMed ID: 37798822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low and differential polygenic score generalizability among African populations due largely to genetic diversity.
    Majara L; Kalungi A; Koen N; Tsuo K; Wang Y; Gupta R; Nkambule LL; Zar H; Stein DJ; Kinyanda E; Atkinson EG; Martin AR
    HGG Adv; 2023 Apr; 4(2):100184. PubMed ID: 36873096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An African perspective on the genetic risk of chronic kidney disease: a systematic review.
    George C; Yako YY; Okpechi IG; Matsha TE; Kaze Folefack FJ; Kengne AP
    BMC Med Genet; 2018 Oct; 19(1):187. PubMed ID: 30340464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenome-wide analysis reveals epistatic associations between APOL1 variants and chronic kidney disease and multiple other disorders.
    Adamson WE; Noyes H; Johnson P; Cooper A; Monckton DG; Ogunsola J; Beckett-Hill G; Sullivan M; Mark P; Parekh RS; MacLeod A
    EBioMedicine; 2024 Mar; 101():105000. PubMed ID: 38360481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and Genetic Characteristics of CKD Patients with High-Risk APOL1 Genotypes.
    Elliott MD; Marasa M; Cocchi E; Vena N; Zhang JY; Khan A; Krishna Murthy S; Bheda S; Milo Rasouly H; Povysil G; Kiryluk K; Gharavi AG
    J Am Soc Nephrol; 2023 May; 34(5):909-919. PubMed ID: 36758113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-Ancestry Polygenic Risk Score for Coronary Heart Disease Based on an Ancestrally Diverse Genome-Wide Association Study and Population-Specific Optimization.
    Smith JL; Tcheandjieu C; Dikilitas O; Iyer K; Miyazawa K; Hilliard A; Lynch J; Rotter JI; Chen YI; Sheu WH; Chang KM; Kanoni S; Tsao PS; Ito K; Kosel M; Clarke SL; Schaid DJ; Assimes TL; Kullo IJ
    Circ Genom Precis Med; 2024 Jun; 17(3):e004272. PubMed ID: 38380516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Genome-Wide Polygenic Scores for Multiple Psychiatric and Common Traits in Preadolescent Youths at Risk of Suicide.
    Joo YY; Moon SY; Wang HH; Kim H; Lee EJ; Kim JH; Posner J; Ahn WY; Choi I; Kim JW; Cha J
    JAMA Netw Open; 2022 Feb; 5(2):e2148585. PubMed ID: 35188556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Genetic Polymorphisms of TGF-β1, HMOX1, and APOL1 With CKD in Nigerian Patients With and Without HIV.
    Ekrikpo UE; Mnika K; Effa EE; Ajayi SO; Okwuonu C; Waziri B; Bello A; Dandara C; Kengne AP; Wonkam A; Okpechi I
    Am J Kidney Dis; 2020 Jul; 76(1):100-108. PubMed ID: 32354559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low prevalence of apolipoprotein L1 gene variants in Black South Africans with hypertension-attributed chronic kidney disease
.
    Nqebelele NU; Dickens C; Dix-Peek T; Duarte R; Naicker S
    Clin Nephrol; 2019 Jan; 91(1):40-47. PubMed ID: 30369398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monogenic and polygenic concepts in chronic kidney disease (CKD).
    Jefferis J; Hudson R; Lacaze P; Bakshi A; Hawley C; Patel C; Mallett A
    J Nephrol; 2024 Jan; 37(1):7-21. PubMed ID: 37989975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polygenic risk alters the penetrance of monogenic kidney disease.
    Khan A; Shang N; Nestor JG; Weng C; Hripcsak G; Harris PC; Gharavi AG; Kiryluk K
    Nat Commun; 2023 Dec; 14(1):8318. PubMed ID: 38097619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiancestral polygenic risk score for pediatric asthma.
    Namjou B; Lape M; Malolepsza E; DeVore SB; Weirauch MT; Dikilitas O; Jarvik GP; Kiryluk K; Kullo IJ; Liu C; Luo Y; Satterfield BA; Smoller JW; Walunas TL; Connolly J; Sleiman P; Mersha TB; Mentch FD; Hakonarson H; Prows CA; Biagini JM; Khurana Hershey GK; Martin LJ; Kottyan L;
    J Allergy Clin Immunol; 2022 Nov; 150(5):1086-1096. PubMed ID: 35595084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.